Legislature(1997 - 1998)
05/06/1997 04:15 PM Senate L&C
| Audio | Topic |
|---|
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
SENATE LABOR AND COMMERCE COMMITTEE
May 6, 1997
4:15 P.M.
MEMBERS PRESENT
Senator Loren Leman, Chairman
Senator Jerry Mackie, Vice Chairman
Senator Mike Miller
Senator Lyman Hoffman
MEMBERS ABSENT
Senator Tim Kelly
COMMITTEE CALENDAR
SENATE BILL NO. 159
"An Act relating to the new business incentive program."
- MOVED CSSB 159(L&C) OUT OF COMMITTEE
HOUSE JOINT RESOLUTION NO. 31
Requesting the United States Congress to amend the Federal Food,
Drug, and Cosmetic Act.
- MOVED HJR 31 OUT OF COMMITTEE
PREVIOUS SENATE COMMITTEE ACTION
SB 159 - See Labor and Commerce minutes dated 4/17/97 and 4/24/97.
HJR 31 - No previous action to consider.
WITNESS REGISTER
Nicole Poirrier, Intern
Representative Pete Kott
State Capitol Bldg.
Juneau AK 99801-1182
POSITION STATEMENT: Staff to sponsor of HJR 31.
ACTION NARRATIVE
TAPE 97-23, SIDE A
Number 001
SB 159 NEW BUSINESS INCENTIVE PROGRAM
CHAIRMAN LEMAN called the Senate Labor and Commerce Committee
meeting to order at 4:15 p.m. and announced SB 159 to be up for
consideration.
SENATOR MACKIE established that the proposed CS included the
changes suggested by AIDEA and moved to adopt the CS to SB 159.
There were no objections and it was so ordered.
SENATOR MACKIE moved to pass CSSB 159(L&C) from committee with
individual recommendations. There were no objections and it was so
ordered.
HJR 31 FEDERAL FOOD, DRUG, AND COSMETIC ACT
CHAIRMAN LEMAN announced HJR 31 to be up for consideration.
NICOLE POIRRIER, intern to Representative Kott, said that HJR 31
asks Congress to amend the federal food, drug, and cosmetic act to
approve drugs and biological products in a more rapid manner while
maintaining patient safety and product effectiveness. The
resolution is very broad and nonspecific and simply encourages
Congress to reexamine the act. Currently it takes about 15 years
for the FDA to approve new medicine in this country.
SENATOR MACKIE moved to pass HJR 31 with individual
recommendations. There were no objections and it was so ordered.
CHAIRMAN LEMAN adjourned the meeting at 4:18 p.m.
| Document Name | Date/Time | Subjects |
|---|